DOI QR코드

DOI QR Code

Large-Scale Production of Cronobacter sakazakii Bacteriophage Φ CS01 in Bioreactors via a Two-Stage Self-Cycling Process

  • Lee, Jin-Sun (Department of Biological Science and Technology, Yonsei University) ;
  • Kim, Gyeong-Hwuii (Department of Biological Science and Technology, Yonsei University) ;
  • Kim, Jaegon (Department of Biological Science and Technology, Yonsei University) ;
  • Lim, Tae-Hyun (Department of Biological Science and Technology, Yonsei University) ;
  • Yoon, Yong Won (Department of Biological Science and Technology, Yonsei University) ;
  • Yoon, Sung-Sik (Department of Biological Science and Technology, Yonsei University)
  • Received : 2021.07.08
  • Accepted : 2021.08.23
  • Published : 2021.10.28

Abstract

Cronobacter sakazakii is an opportunistic pathogenic bacterium found in powdered infant formula and is fatal to neonates. Antibiotic resistance has emerged owing to overuse of antibiotics. Therefore, demand for high-yield bacteriophages as an alternative to antibiotics has increased. Accordingly, we developed a modified mass-production method for bacteriophages by introducing a two-stage self-cycling (TSSC) process, which yielded high-concentration bacteriophage solutions by replenishing the nutritional medium at the beginning of each process, without additional challenge. pH of the culture medium was monitored in real-time during C. sakazakii growth and bacteriophage CS01 propagation, and the changes in various parameters were assessed. The pH of the culture medium dropped to 5.8 when the host bacteria reached the early log phase (OD540 = 0.3). After challenge, it decreased to 4.65 and then recovered to 4.94; therefore, we set the optimum pH to challenge the phage at 5.8 and that to harvest the phage at 4.94. We then compared phage production during the TSSC process in jar-type bioreactors and the batch culture process in shaker flasks. In the same volume of LB medium, the concentration of the phage titer solution obtained with the TSSC process was 24 times higher than that obtained with the batch culture process. Moreover, we stably obtained high concentrations of bacteriophage solutions for three cycles with the TSSC process. Overall, this modified TSSC process could simplify large-scale production of bacteriophage CS01 and reduce the unit cost of phage titer solution. These results could contribute to curing infants infected with antibiotic-resistant C. sakazakii.

Keywords

Acknowledgement

This study was funded by a grant from the National Research Foundation of Korea (Grant no. 2015R1D1A1A01058374).

References

  1. Drudy D, Mullane NR, Quinn T, Wall PG, Fanning S. 2006. Enterobacter sakazakii: an emerging pathogen in powdered infant formula. Clin. Infect. Dis. 42: 996-1002. https://doi.org/10.1086/501019
  2. Hunter CJ, Bean JF. 2013. Cronobacter: an emerging opportunistic pathogen associated with neonatal meningitis, sepsis and necrotizing enterocolitis. J. Perinatol. 33: 581-585. https://doi.org/10.1038/jp.2013.26
  3. Hariri S, Joseph S, Forsythe SJ. 2013. Cronobacter sakazakii ST4 strains and neonatal meningitis, United States. Emerg. Infect. Dis. 19: 175-177. https://doi.org/10.3201/eid1901.120649
  4. Wittebole X, De Roock S, Opal SM. 2014. A historical overview of bacteriophage therapy as an alternative to antibiotics for the treatment of bacterial pathogens. Virulence 5: 226-235. https://doi.org/10.4161/viru.25991
  5. Moghadam MT, Amirmozafari N, Shariati A, Hallajzadeh M, Mirkalantari S, Khoshbayan A, et al. 2020. How phages overcome the challenges of drug resistant bacteria in clinical infections. Infect. Drug Resist. 13: 45-61. https://doi.org/10.2147/idr.s234353
  6. Loc-Carrillo C, Abedon ST. 2011. Pros and cons of phage therapy. Bacteriophage 1: 111-114. https://doi.org/10.4161/bact.1.2.14590
  7. Morozova VV, Vlassov VV, Tikunova NV. 2018. Applications of bacteriophages in the treatment of localized infections in humans. Front. Microbiol. 9: 1696. https://doi.org/10.3389/fmicb.2018.01696
  8. Garcia P, Martinez B, Obeso JM, Rodriguez A. 2008. Bacteriophages and their application in food safety. Lett. Appl. Microbiol. 47: 479-485. https://doi.org/10.1111/j.1472-765X.2008.02458.x
  9. Kim GH, Kim J, Kim KH, Lee JS, Lee NG, Lim TH, et al. 2019. Characterization and genomic analysis of novel bacteriophage Phi CS01 targeting Cronobacter sakazakii. J. Microbiol. Biotechnol. 29: 696-703. https://doi.org/10.4014/jmb.1812.12054
  10. Bakhshinejad B, Sadeghizadeh M. 2014. Bacteriophages and development of nanomaterials for neural regeneration. Neural Regen Res. 9: 1955-1958. https://doi.org/10.4103/1673-5374.145371
  11. Sauvageau D, Cooper DG. 2010. Two-stage, self-cycling process for the production of bacteriophages. Microb. Cell Fact. 9: 81. https://doi.org/10.1186/1475-2859-9-81
  12. Zwietering MH, Jongenburger I, Rombouts FM, van 't Riet K. 1990. Modeling of the bacterial growth curve. Appl. Environ. Microbiol. 56: 1875-1881. https://doi.org/10.1128/aem.56.6.1875-1881.1990
  13. Bourdin G, Schmitt B, Guy LM, Germond JE, Zuber S, Michot L, et al. 2014. Amplification and purification of T4-Like Escherichia coli phages for phage therapy: from laboratory to pilot scale. Appl. Environ. Microbiol. 80: 1469-1476. https://doi.org/10.1128/AEM.03357-13
  14. Yamamoto KR, Alberts BM, Benzinger R, Lawhorne L, Treiber G. 1970. Rapid bacteriophage sedimentation in the presence of polyethylene glycol and its application to large-scale virus purification. Virology 40: 734-744. https://doi.org/10.1016/0042-6822(70)90218-7
  15. Moce-Llivina L, Lucena F, Jofre J. 2004. Double-layer plaque assay for quantification of enteroviruses. Appl. Environ. Microbiol. 70: 2801-2805. https://doi.org/10.1128/AEM.70.5.2801-2805.2004
  16. Kropinski AM. 2018. Practical advice on the one-step growth curve. Methods Mol Biol. 1681: 41-47. https://doi.org/10.1007/978-1-4939-7343-9_3
  17. Sauvageau D, Storms Z, Cooper DG. 2010. Synchronized populations of Escherichia coli using simplified self-cycling fermentation. J. Biotechnol. 149: 67-73. https://doi.org/10.1016/j.jbiotec.2010.06.018
  18. Agboluaje M, Sauvageau D. 2018. Bacteriophage Production in Bioreactors, pp. 173-193. In Azeredo J, Sillankorva S (eds.), Bacteriophage Therapy: From Lab to Clinical Practice, Ed. Springer New York, New York, USA.
  19. Fauquet CM, Fargette D. 2005. International committee on taxonomy of viruses and the 3,142 unassigned species. Virol. J. 2: 64. https://doi.org/10.1186/1743-422X-2-64
  20. Ackermann HW. 2012. Bacteriophage electron microscopy. Adv. Virus Res. 82: 1-32. https://doi.org/10.1016/B978-0-12-394621-8.00017-0
  21. Repaske R. 1956. Lysis of gram-negative bacteria by lysozyme. Biochim. Biophys. Acta 22: 189-191. https://doi.org/10.1016/0006-3002(56)90240-2